Tumour heterogeneity and resistance to cancer therapies

Tumour heterogeneity and resistance to cancer therapiesTumour heterogeneity and resistance to cancer therapies, Published online: 08 November 2017; doi:10.1038/nrclinonc.2017.166NatureArticleSnippet(type=short-summary, markup=The onset of acquired resistance to treatment is virtually inevitable in patients with solid tumours. In this Review, the authors describe the role of tumour heterogeneity in the development of acquired resistance, potential treatment strategies that take into account the heterogeneity of patient's tumours, and how a better understanding of tumour heterogeneity might improve the outcomes of patients., isJats=true)
Source: Nature Clinical Practice Oncology - Category: Cancer & Oncology Authors: Source Type: research